A remote hypertension and cholesterol management program is effective for reducing BP and LDL cholesterol, according to a study
published in JAMA Cardiology. Alexander J. Blood, MD, and colleagues implemented and evaluated a remote hypertension and cholesterol management program among 10,803 patients. A total of 1,266 patients requested education only; others received education, home BP device integration, and medication titration. Overall, 424,482 BP readings and 139,263 laboratory reports were collected. The mean clinic BP at 6 and 12 months after enrollment decreased by 8.7/3.8 mmHg and 9.7/5.2 mmHg, respectively, for those engaged in remote medication management. The corresponding changes in BP were −1.5/−0.7 mmHg and +0.2/−1.9 mmHg, respectively, in the education-only cohort. Patients in the remote group experienced a mean reduction in LDL cholesterol of 35.4 mg/dL and 37.5 mg/dL at 6 and 12 months, respectively, in the lipids program.
